DeepSP: Deep learning-based spatial properties to predict monoclonal antibody stability
- PMID: 38827232
- PMCID: PMC11140563
- DOI: 10.1016/j.csbj.2024.05.029
DeepSP: Deep learning-based spatial properties to predict monoclonal antibody stability
Abstract
Therapeutic antibody development faces challenges due to high viscosities and aggregation tendencies. The spatial charge map (SCM) and spatial aggregation propensity (SAP) are computational techniques that aid in predicting viscosity and aggregation, respectively. These methods rely on structural data derived from molecular dynamics (MD) simulations, which are computationally demanding. DeepSCM, a deep learning surrogate model based on sequence information to predict SCM, was recently developed to screen high-concentration antibody viscosity. This study further utilized a dataset of 20,530 antibody sequences to train a convolutional neural network deep learning surrogate model called Deep Spatial Properties (DeepSP). DeepSP directly predicts SAP and SCM scores in different domains of antibody variable regions based solely on their sequences without performing MD simulations. The linear correlation coefficient between DeepSP scores and MD-derived scores for 30 properties achieved values between 0.76 and 0.96 with an average of 0.87. DeepSP descriptors were employed as features to build machine learning models to predict the aggregation rate of 21 antibodies, and the performance is similar to the results obtained from the previous study using MD simulations. This result demonstrates that the DeepSP approach significantly reduces the computational time required compared to MD simulations. The DeepSP model enables the rapid generation of 30 structural properties that can also be used as features in other research to train machine learning models for predicting various antibody stability using sequences only. DeepSP is freely available as an online tool via https://deepspwebapp.onrender.com and the codes and parameters are freely available at https://github.com/Lailabcode/DeepSP.
Keywords: Antibody stability; Deep learning; Molecular dynamics simulation; Monoclonal antibody; Spatial aggregation propensity; Spatial charge map.
© 2024 The Authors.
Conflict of interest statement
There is no conflict of interest.
Figures






Similar articles
-
Accelerating high-concentration monoclonal antibody development with large-scale viscosity data and ensemble deep learning.MAbs. 2025 Dec;17(1):2483944. doi: 10.1080/19420862.2025.2483944. Epub 2025 Apr 1. MAbs. 2025. PMID: 40170162 Free PMC article.
-
Machine Learning Models for Predicting Monoclonal Antibody Biophysical Properties from Molecular Dynamics Simulations and Deep Learning-Based Surface Descriptors.Mol Pharm. 2025 Jan 6;22(1):142-153. doi: 10.1021/acs.molpharmaceut.4c00804. Epub 2024 Nov 28. Mol Pharm. 2025. PMID: 39606945
-
DeepSCM: An efficient convolutional neural network surrogate model for the screening of therapeutic antibody viscosity.Comput Struct Biotechnol J. 2022 Apr 29;20:2143-2152. doi: 10.1016/j.csbj.2022.04.035. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 35832619 Free PMC article.
-
DeepSP: A Deep Learning Framework for Spatial Proteomics.J Proteome Res. 2023 Jul 7;22(7):2186-2198. doi: 10.1021/acs.jproteome.2c00394. Epub 2023 Jun 14. J Proteome Res. 2023. PMID: 37314414
-
Machine learning prediction of antibody aggregation and viscosity for high concentration formulation development of protein therapeutics.MAbs. 2022 Jan-Dec;14(1):2026208. doi: 10.1080/19420862.2022.2026208. MAbs. 2022. PMID: 35075980 Free PMC article.
Cited by
-
Accelerating high-concentration monoclonal antibody development with large-scale viscosity data and ensemble deep learning.MAbs. 2025 Dec;17(1):2483944. doi: 10.1080/19420862.2025.2483944. Epub 2025 Apr 1. MAbs. 2025. PMID: 40170162 Free PMC article.
-
PROPERMAB: an integrative framework for in silico prediction of antibody developability using machine learning.MAbs. 2025 Dec;17(1):2474521. doi: 10.1080/19420862.2025.2474521. Epub 2025 Mar 5. MAbs. 2025. PMID: 40042626 Free PMC article.
References
-
- Bhambhani A., Kissmann J.M., Joshi S.B., Volkin D.B., Kashi R.S., Middaugh C.R. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions. J Pharm Sci. 2012;101(3):1120–1135. doi: 10.1002/jps.23008. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous